Hoow Foods is a Singapore foodtech startup that has launched a subsidiary, Hegg Foods, to commercialize a plant-based egg product called HEGG. HEGG was developed using Hoow Foods’ RE-GENESYS ingredient-informatics AI platform and is positioned as a lower-fat, cholesterol-free egg alternative free of growth hormones and antibiotics. The product is intended to reduce carbon footprint and land use compared with conventional eggs and to be applicable across Western and Asian cuisines. Hoow Foods recently announced a $3 million Pre-Series A round, and Hegg Foods has secured an angel investment to expand its R&D capabilities. The company is planning pilot-scale production and targeted commercialization of HEGG by the first half of 2022 and aims to establish a manufacturing facility in Singapore within two years. Hoow Foods frames HEGG as a contribution to Singapore’s “30 by 30” goal and aims to reduce the country’s dependence on egg imports by 20% within five years. Hoow Foods applies a drug-development-inspired approach to reformulate everyday foods into healthier alternatives, aiming to prevent metabolic diseases such as diabetes and obesity. The team combines food science, pharmaceutical development practices and data science to break products into physical and chemical building blocks and predict viable formulations. Its pipeline includes a staple foods moderator to alter the glycemic index of staples and finished products such as Callery’s ice cream, which the company says has ~77% fewer calories, 80% less sugar and 77% less total fat than an average premium ice cream. The startup offers consulting and outsourced R&D to food companies and has commercial partnerships, including with Killiney Group, which has co-developed healthier tea and coffee products with Hoow Foods. Hoow plans to fully automate its development platform using AI and ultimately license it as a software-as-a-service product, while continuing to sell reformulated finished products and consulting services. Recent funding will be used to hire scientists, build tech infrastructure, and expand R&D capabilities across the region.

Total raised

$3M

Funding rounds

2

Latest round

Series A

Latest activity

Aug 2021